WHO Global Surveillance and Monitoring System SSFFC Medical Products (Substandard, Spurious, Falsely labelled, Falsified and Counterfeit)
|
|
|
- Harriet Eaton
- 5 years ago
- Views:
Transcription
1 WHO Global Surveillance and Monitoring System SSFFC Medical Products (Substandard, Spurious, Falsely labelled, Falsified and Counterfeit) TECHNICAL BRIEFING SEMINAR 2016
2 What does SSFFC mean? Counterfeit Medicine Falsificado Medicamento Falsified Medicine Counterfeit Medicine Spurious Medicine Counterfeit Medicine Fake/ Substandard Medicine Counterfeit Medicine Fraudulent, Falsely labelled, Forged, Copied, Adulterated, Pirated, Fake
3 Substandard Medical Product Registered medical product Sub Standard Out of specification due to degraded, expired, or manufacturing error Genuine Medical Product (manufactured in compliance with National Specifications)
4 Substandard Medical Product Isosorbide-5-Mononitrate Paracetamol Also called out of specification (OOS) products, are genuine medicines produced by manufacturers authorized by the National Medicines Regulatory Authority (NMRA) which do not meet quality specifications set for them by National standards.
5 Falsified Medical Product Unregistered medical product Falsified Deliberately Misrepresents its identity, composition or source
6 Falsified Medical Product Heart Disease Cancer Anti-malarial Medical Products which deliberately misrepresent either their identity, and /or composition, and/or source
7 Working Definitions Surveillance and Monitoring System Unregistered medical product Unregistered Not licensed or assessed for safety, quality and efficacy in Country of marketing
8 Unregistered medical Product Medical products which are not authorized by the competent medicines regulatory authority for marketing and distribution, and have not undergone evaluation of their safety, efficacy and quality for the market in which they are distributed
9 Working Definitions Surveillance and Monitoring System Registered medical product Unregistered medical product Sub Standard Falsified Unregistered Out of specification due to degraded, expired, or manufacturing error Deliberately Misrepresents its identity, composition or source Not licensed or assessed for safety, quality and efficacy in Country of marketing Genuine Medical Product (manufactured in compliance with National Specifications)
10 Democratic Republic of Congo hospitalizations: up to 40 per week Acute dystonic reaction affecting face, neck upper limbs, particularly in young persons Limited access to medicines MSF investigate root cause and inform WHO Surveillance and Monitoring system
11 Democratic Republic of Congo 2015
12 Toxic Reactions Falsified Diazepam Container of 1000 tablets Labelled Diazepam Laboratory analysis confirms zero Diazepam but presence of Haloperidol Haloperidol is used for the treatment of Schizophrenia
13 WHO Member State Mechanism MANDATE GOVERNANCE PURPOSE World Health Assembly Chair 11 vice Chairs Regional rotation International collaboration from a public health perspective on sub-standard, spurious, falsely labelled, falsified and counterfeit (SSFFC) medical products
14 CURRENT ACTIVITIES Developing National Strategies and Training Field Detection Technologies Risk Communication and Awareness Definitions Global Focal Point Network Socio Economic study of the public health impact of SSFFC medical products
15 WHO Global Surveillance System Available in English, French, Spanish and Portuguese 125 Member States trained Over 400 Regulatory personnel trained 18 large procurement agencies sensitized Over 1300 Suspect Products Reported Incidents occurred in 90 countries 17 WHO Global Drug alerts and numerous warnings WHO Technical Assistance in over 100 Cases
16 Globalization = Increased Vigilance December 2012, Pakistan 50 deaths WHO International Alert Colombia and Peru trace the API September 2013, Paraguay 46 patients hospitalised Global Impact 8 Countries 4 Continents WHO International Alert
17 Reports by Region African Region 47% European Region Region of the Americas 21% Western Pacific Region 2% 5% 8% 17% Eastern Mediterranean Region South-East Asia Region
18 What's the harm for public health? Patients and consumers health Confidence in medicines, healthcare providers, health systems Anti microbial resistance Undermining vaccination programmes Economic damage to health systems, loss of productivity, prolonged treatment regimes Increased out of pocket expenses to consumers
19 Reported Therapeutic Categories Antiparasitic products, insecticides and Antiinfectives for systemic use Nervous system Genito-urinary system and sex hormones Antineoplastic and immunomodulating Alimentary tract and metabolism Musculo-skeletal system Respiratory system Cardiovascular system Various Systemic hormonal preparations Blood and blood forming organs Sensory organs Dermatologicals
20 AFRICAN CUSTOMS SEIZURE ANGOLA Coartem Anti malarial 1.383,528 packs Postinor 2 Emergency Contraceptive 4930 packs Vermox Worming treatment 1534 packs Clomid Fertility treatment 36,550 packs Clamoxyl - Antibiotic 744 packs
21 IMPORTANCE OF NETWORKS (WEST AFRICA )
22 Falsified Antibiotics by API (Global) Phenoxymethylpenicillin, 7% Ampicillin, 7% Sulfamethoxazole, 16% 4% Amoxicillin 24% 3% 23% 2% 1% Amoxicillin Sulfamethoxazole Ampicillin Phenoxymethylpenicillin Clarithromycin Gentamicin Cloxacillin ceftriaxone Lincomycin Ciprofloxacin Cefuroxime Fusidic Acid Ceftazidime Benzylpenicillin Chloramphenicol Doxycycline Nitrofurantoin Penicillin Oxacillin Azithromycin Dihydrate Amikacin sulfate Cefpodoxime Ofloxacin Levofloxacin Pefloxacin Benzathine benzylpenicillin Sulfanilamide Linezolid Erythromycin Stearate Nalidixic Acid Erythromycin
23 Reproductive Health Products Laboratory analysis indicate zero Active Pharmaceutical Ingredient Available in public and private health care facilities Frequently WHO pre qualified products Frequently genuine batch numbers
24 Falsified Vaccines (Source: National Ministries of Health Alerts and Govt Press releases) 1995 Niger Meningitis 2015 Meningitis Shortage Public Supply 2010 China Rabies 2500 Deaths 1 Death Arrests 2013 Rabies 10,800 Doses 17 Arrests 2009 Philippines Influenza Tetanus Rabies Vaccine Clinics 2016 Indonesia Hepatitis B Tuberculosis Polio Tetanus 23 Arrests 2010 Cameroon Meningitis High prices Stock Shortage 2016 Bangladesh Yellow Fever
25 VULNERABILITIES Access Affordability Availability Quality Governance Poor Procurement Corruption Unethical practice Supply Chain Integrity Porous Borders Weak Regulatory oversight Medical Products On-line
26 New Initiatives SMART PHONE APPLICATION WHO PORTAL SEARCH TOOL HCP NMRA WHO
27
28
29
30 Michael Deats Group Lead, SSFFC Medical Products Pernette Bourdillon-Esteve System Analyst Diana Lee Technical Officer
EUCAST recommended strains for internal quality control
EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC
Quality of 2 nd line medicines for tuberculosis. Ms Lisa Hedman World Health Organization Department of Essential Medicines and Health Products
Quality of 2 nd line medicines for tuberculosis Ms Lisa Hedman World Health Organization Department of Essential Medicines and Health Products Case studies in medicines for tuberculosis Outline: Statistics
Counterfeit drugs: Experience of West Africa
Counterfeit drugs: Experience of West Africa Regional Seminar for OIE National Focal Points for Veterinary Products 4th Cycle, Entebbe, Uganda, 1-3 December 2015 A. TEKO-AGBO, A. ASSOUMY, E. M. NIANG LACOMEV,
21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review
(1) Have all important studies/evidence of which you are aware been included in the application? Yes No Please provide brief comments on any relevant studies that have not been included: (2) For each of
AMR Industry Alliance Antibiotic Discharge Targets
AMR Industry Alliance Antibiotic Discharge Targets List of Predicted No-Effect Concentrations (PNECs) The members of the AMR Industry Alliance have developed a unified approach to establishing discharge
Routine internal quality control as recommended by EUCAST Version 3.1, valid from
Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus
Compliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
European Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
Compliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV
Empiric Antibiotics for Pediatric Infections Seen in ED NOTE: Choice of empiric antibiotic therapy must take into account local pathogen frequency and resistance patterns, individual patient characteristics,
Introduction. Antimicrobial Usage ESPAUR 2014 Previous data validation Quality Premiums Draft tool CDDFT Experience.
Secondary Care Data Validation: What do commissioners need to know? Stuart Brown Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England March 2014 Introduction Antimicrobial
What s new in EUCAST methods?
What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests
Quality of veterinary medicines
Quality of veterinary medicines Regional Seminar for OIE National Focal Points for Veterinary Products Tokyo, 2 March 2016 Dr. Yoshihiro Shimizu, DVM Executive Director, Asian Animal Health Association
European Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01
National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults
National Clinical Guideline Centre Antibiotic classifications Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix N 3 December 2014
Childrens Hospital Antibiogram for 2012 (Based on data from 2011)
Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical
The OIE activities to protect animal and human health: Potential contributions in the fight against counterfeit drugs
Mária Szabó Chargée de mission The OIE activities to protect animal and human health: Potential contributions in the fight against counterfeit drugs WCO Knowledge Academy Brussels, 22 June 2017 Summary
- the details, where possible, of the antibiotic products these companies supply or have supplied.
Under the Freedom of Information Act 2000 please could you provide me with a list of all companies currently supplying antibiotics - or that have supplied antibiotics in the last three years - to Royal
Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018
Antimicrobial Update Alison MacDonald Area Antimicrobial Pharmacist NHS Highland alisonc.macdonald@nhs.net April 2018 Starter Questions Setting the scene... What if antibiotics were no longer effective?
a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
Illegal veterinary medicines
Illegal veterinary medicines Regional Seminar for OIE National Focal Points for Veterinary Products Beirut, Lebanon, 7-9 November 2017 Philippe Sabot on behalf of HealthforAnimals. www.animalhealthmatters.org
Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe
Interactive session: adapting to antibiogram Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe Case 1 63 y old woman Dx: urosepsis? After 2 d: intermediate result: Gram-negative bacilli Empiric antibiotic
GENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
Jaipur Declaration on Antimicrobial Resistance
Jaipur Declaration on Antimicrobial Resistance We, the Health Ministers of Member States of the WHO South-East Asia Region participating in the Twenty-ninth Health Ministers Meeting in Jaipur, India, appreciate
Approach to pediatric Antibiotics
Approach to pediatric Antibiotics Gassem Gohal FAAP FRCPC Assistant professor of Pediatrics objectives To be familiar with common pediatric antibiotics o Classification o Action o Adverse effect To discus
2016 Antibiotic Susceptibility Report
Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates
Quality of veterinary medicines
Quality of veterinary medicines Regional Seminar for OIE National Focal Points for Veterinary Products Entebbe, Uganda, 1-3 December 2015 Olivier Espeisse (Elanco), speaking on behalf of HealthforAnimals
I am writing in response to your request for information made under the Freedom of Information Act 2000 in relation to Antibiotics.
Ref: FOI/CAD/ID 3459 27 June 2017 Please reply to: FOI Administrator Trust Management Maidstone Hospital Hermitage Lane Maidstone Kent ME16 9QQ Email: mtw-tr.foiadmin@nhs.net Freedom of Information Act
2015 Antibiotic Susceptibility Report
Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens
INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT
INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT Name & Title Of Authors: Dr M Milupi, Consultant Microbiologist Dr N Rao,Consultant Paediatrician Dr V Desai Consultant Paediatrician Date Revised: DEC 2015
1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient
1 Chapter 79, Self-Assessment Questions 1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient with normal renal function is: A. Trimethoprim-sulfamethoxazole B. Cefuroxime
PRODUCTS LIST INFECTIOLOGY
PRODUCTS LIST THERAPEUTIC CLASS REF. PRODUCT DESIGNATION CONDITIONNING 1ACIC200 Aciclovir 200mg 500 tabs 2ACIC200 Aciclovir 200mg 500 tabs blister 1ACIC400 Aciclovir 400mg 500 tabs 2ACIC400 Aciclovir 400mg
GENERAL PRESENTATION OF THE OIE
GENERAL PRESENTATION OF THE OIE Regional Seminar for OIE National Focal Points for Veterinary Products (4 th Cycle) 2-4 March 2016 Tokyo, Japan 1 THE OIE IN BRIEF 2 What is the OIE? An intergovernmental
INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT
INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT Name & Title Of Authors: Dr M Milupi, Consultant Microbiologist Dr N Rao,Consultant Paediatrician Dr V Desai Consultant Paediatrician Date Revised: APRIL
SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* ...
SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* The next-generation MicroScan WalkAway System combines proven technology and reliability with enhanced ease-of-use features to streamline
PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS
PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS The current supply of piperacillin- tazobactam should be reserved f Microbiology / Infectious Diseases approval and f neutropenic sepsis, severe sepsis
Microbiology : antimicrobial drugs. Sheet 11. Ali abualhija
Microbiology : antimicrobial drugs Sheet 11 Ali abualhija return to our topic antimicrobial drugs, we have finished major group of antimicrobial drugs which associated with inhibition of protein synthesis
Antimicrobial Susceptibility Testing: Advanced Course
Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to
2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #116 (NQF 0058): Avoidance of Antibiotic Treatment in Adults With Acute Bronchitis National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY
3 party manufacturing PRODUCT LIST. Category : ANTI BIOTIC
rd 3 party manufacturing PRODUCT LIST Category : ANTI BIOTIC ANTI BIOTIC SR.NO. COMPOSTION DRUG/FOOD DOSAGE PACKING 1 Amikacin Sulphate IP 500mg/2ml DRUG LIQUID INJ. VIAL 2 Amoxicillin 200mg & Clavulanic
EAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia
EAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia Background The Expert Advisory Group on Antimicrobial Resistance of the NH&MRC provides advice to Australian governments and
SIMAGCHEM CORPORATION
SIMAGCHEM CORPORATION Corporation SIMAGCHEM was established in 1996. We are a dynamic and innovative chemical supplier company based in China. In term of our teamwork and EPR -BDL database, we are professional
GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP
GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP CO-AMOXICLAV (AMOXICILLIN + CLAVULANATE) Dr. Marie-Claude BOTTINEAU Dr. Emmanuel BARON Summary of global estimates (CHERG 2013) ~ 6.6 million deaths
International Health and Medicine, Graduate School of Tokyo Medical and Dental University, Yushima, Bunkyo-ku Tokyo, Japan
Research Article Antimicrobial use in a country with insufficient enforcement of pharmaceutical regulations: A survey of consumption and retail sales in Ulaanbaatar, Mongolia Rie Nakajima 1, Takehito Takano
Interventions: Disease Prevention and Antimicrobial Use Reduction - Overview
Global Antibiotic Resistance Partnership South Africa Inaugural meeting. Stellenbosch, South Africa 8-9 Feb, 2010 Interventions: Disease Prevention and Antimicrobial Use Reduction - Overview Iruka N Okeke
Quality of Veterinary Medicinal Products. How to ensure the quality of Veterinary Medicinal Products
Quality of Veterinary Medicinal Products How to ensure the quality of Veterinary Medicinal Products Jean-Pierre Orand Anses/ANMV OIE Collaborating Centre on Veterinary medicinal products Jean-pierre.orand@anses.fr
Urgent Product Correction Notice FSCA This is to inform you of an Urgent Product Correction Notice involving:
20 April 2017 Urgent Product Correction Notice FSCA 3445 Dear This is to inform you of an Urgent Product Correction Notice involving: VITEK 2 Identification / Antimicrobial Susceptibility Test Cards referenced
General Directorate of Animal Health and EpizooticDiseases Control. Dr.Sabah Hassan Abdelgadir Sudan Focal Point for Veterinary products
REPUBLIC OF SUDAN Ministry of Animal Resources General Directorate of Animal Health and EpizooticDiseases Control Dr.Sabah Hassan Abdelgadir Sudan Focal Point for Veterinary products Sudan experiences
QUALITY HEALTH CARE YOUR PREFERRED PARTNER IN. For better health
YOUR PREFERRED PARTNER IN QUALITY HEALTH CARE For better health Manufacturer of Pharmaceutical Products Eka Pharma 308, Samanvay Zillion, Gotri - Sevasi Road, Opp. Shaishav School, Vadodara-391 101, (Guj.)
International Food Safety Authorities Network (INFOSAN) Antimicrobial Resistance from Food Animals
International Food Safety Authorities Network (INFOSAN) 7 March 2008 INFOSAN Information Note No. 2/2008 - Antimicrobial Resistance Antimicrobial Resistance from Food Animals SUMMARY NOTES Antimicrobial
Considerations in antimicrobial prescribing Perspective: drug resistance
Considerations in antimicrobial prescribing Perspective: drug resistance Hasan MM When one compares the challenges clinicians faced a decade ago in prescribing antimicrobial agents with those of today,
Antibiotic Susceptibility of Common Bacterial Pathogens in Canine Urinary Tract Infections
Vol.1 No.2 Oct-Dec 2013 ISSN : 2321-6387 Antibiotic Susceptibility of Common Bacterial Pathogens in Canine Urinary Tract Infections S. Yogeshpriya*, Usha N.Pillai, S. Ajithkumar and N. Madhavan Unny Department
Consumption of antibiotics in hospitals. Antimicrobial stewardship.
Consumption of antibiotics in hospitals. Antimicrobial stewardship. Inge C. Gyssens MD PhD Radboud university medical center, Nijmegen, The Netherlands Hasselt University, Belgium 1. Antibiotic use in
Received: Accepted: Access this article online Website: Quick Response Code:
Indian Journal of Drugs, 2016, 4(3), 69-74 ISSN: 2348-1684 STUDY ON UTILIZATION PATTERN OF ANTIBIOTICS AT A PRIVATE CORPORATE HOSPITAL B. Chitra Department of Pharmacy Practice, College of Pharmacy, Sri
3/23/2017. Kathryn G. Smith, PharmD PGY1 Pharmacy Resident Via Christi Hospitals Wichita, Inc. Kathryn G. Smith: Nothing to disclose
Kathryn G. Smith, PharmD PGY1 Pharmacy Resident Via Christi Hospitals Wichita, Inc Kathryn G. Smith: Nothing to disclose Describe the new updates and rationale for them Relay safety concerns with use of
https://www.indiamart.com/healthbiotech/
+91-8079454100 Health Biotech Limited https://www.indiamart.com/healthbiotech/ The top most leading manufacturing company offers best quality range of broad portfolio of finished Pharmaceutical Formulations.
Report on Point Prevalence Survey of Antibacterial Prescribing at Ysbyty Gwynedd Hospital November 2008
Report on Point Prevalence Survey of Antibacterial Prescribing at Ysbyty Gwynedd Hospital November 2008 Authors: Maggie Heginbothom Robin Howe Version: 1 Antibacterial PPS Ysbyty Gwynedd Date: 29/05/2009
Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016
Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate
OIE Collaborating Centres Reports Activities
OIE Collaborating Centres Reports Activities Activities in 2017 This report has been submitted : 2018-01-13 02:04:00 Title of collaborating centre: Diagnosis and Vaccine Evaluation in the Address of Collaborating
Antimicrobial Resistance at human-animal interface in the Asia-Pacific Region
Antimicrobial Resistance at human-animal interface in the Asia-Pacific Region Gyanendra Gongal Scientist International Health and Regulations Health Security and Emergency Response WHO South-East Asia
SAFE, SECURE AND CONTROLLED: MANAGING THE SUPPLY CHAIN OF ANTIMICROBIALS
SAFE, SECURE AND CONTROLLED: MANAGING THE SUPPLY CHAIN OF ANTIMICROBIALS THE REVIEW ON ANTIMICROBIAL RESISTANCE CHAIRED BY JIM O NEILL NOVEMBER 2015 1 INTRODUCTION Antimicrobial drugs such as those used
DR. BASHIRU BOI KIKIMOTO
OVERVIEW OF ANTIMICROBIAL RESISTANCE AND ANTIMICROBIAL USE IN GHANA PRESENTED BY : DR. BASHIRU BOI KIKIMOTO DVM. PhD VETERINARY PUBLIC HEALTH HEAD - PUBLIC HEALTH UNIT & FOOD SAFETY UNIT VENUE: SWATZILAND
January 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton
3. records of distribution for proteins and feeds are being kept to facilitate tracing throughout the animal feed and animal production chain.
CANADA S FEED BAN The purpose of this paper is to explain the history and operation of Canada s feed ban and to put it into a broader North American context. Canada and the United States share the same
YOUR COMPLETE SOURCE FOR MEDICAL MISSIONS SUPPLIES.
YOUR COMPLETE SOURCE FOR MEDICAL MISSIONS SUPPLIES. When disasters strike, Blessings International provides pharmaceuticals and medical supplies quickly, so you can bring healing to the hurting. Where
Intrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
Advanced Practice Education Associates. Antibiotics
Advanced Practice Education Associates Antibiotics Overview Difference between Gram Positive(+), Gram Negative(-) organisms Beta lactam ring, allergies Antimicrobial Spectra of Antibiotic Classes 78 Copyright
An agency of the European Union
An agency of the European Union Human medicines in 23 Research and development 473 overall number of scientific advice and protocol assistance requests received in 23
Antimicrobial Susceptibility Testing: The Basics
Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories
Rational management of community acquired infections
Rational management of community acquired infections Dr Tanu Singhal MD, MSc Consultant Pediatrics and Infectious Disease Kokilaben Dhirubhai Ambani Hospital, Mumbai Why is rational management needed?
Cell Wall Weakeners. Antimicrobials: Drugs that Weaken the Cell Wall. Bacterial Cell Wall. Bacterial Resistance to PCNs. PCN Classification
Cell Wall Weakeners Antimicrobials: Drugs that Weaken the Cell Wall Beta Lactams Penicillins Cephalosporins Carbapenems Aztreonam Vancomycin Teicoplanin Bacterial Cell Wall Bacterial cytoplasm is hypertonic
Antibiotic Stewardship Program (ASP) CHRISTUS SETX
Antibiotic Stewardship Program (ASP) CHRISTUS SETX Program Goals I. Judicious use of antibiotics Decrease use of broad spectrum antibiotics and deescalate use based on clinical symptoms Therapeutic duplication:
Antimicrobial susceptibility
Antimicrobial susceptibility PATTERNS Microbiology Department Canterbury ealth Laboratories and Clinical Pharmacology Department Canterbury District ealth Board March 2011 Contents Preface... Page 1 ANTIMICROBIAL
Dr Elisabeth Erlacher Vindel Head of Science and New Technologies Departement OIE AMR strategy and activities related to animal health
Dr Elisabeth Erlacher Vindel Head of Science and New Technologies Departement OIE AMR strategy and activities related to animal health Regional Workshop for National Focal Points for Veterinary Products
Lyme disease: diagnosis and management
National Institute for Health and Care Excellence Final Lyme disease: diagnosis and management [D] Evidence review for the management of erythema migrans NICE guideline 95 Evidence review April 2018 Final
MALAYSIA NATIONAL ACTION PLAN ON ANTIMICROBIAL RESISTANCE (AMR) ANIMAL HEALTH
MALAYSIA NATIONAL ACTION PLAN ON ANTIMICROBIAL RESISTANCE (AMR) ANIMAL HEALTH DR. SAIPUL BAHARI BIN ABDUL REE DEPARTMENT OF VETERINARY SERVICES WISMA TANI, LEVEL 5, PODIUM BLOCK 1A, LOT 4G1, PRECINT 4,
Rate In Rs.Ps (ED Included. Tax Extra) Sl No Name Of The Product Pack. Scheduled And Non-Scheduled Formulations Capsules
KAPL list of products applicable for Institutional/Hospital supplies under Pharmaceuticals Purchase Policy (PPP) issued by Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt. of India
Antibiotic Usage Guidelines in Hospital
SUPPLEMENT TO JAPI december VOL. 58 51 Antibiotic Usage Guidelines in Hospital Camilla Rodrigues * Use of surveillance data information of Hospital antibiotic policy guidelines from Hinduja Hospital. The
of Conferences of OIE Regional Commissions organised since 1 June 2013 endorsed by the Assembly of the OIE on 29 May 2014
of Conferences of OIE Regional Commissions organised since 1 June 2013 endorsed by the Assembly of the OIE on 29 May 2014 2 12 th Conference of the OIE Regional Commission for the Middle East Amman (Jordan),
Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani
Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani 30-1-2018 1 Objectives of the lecture At the end of lecture, the students should be able to understand the following:
Antimicrobial Susceptibility Patterns
Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department
Illegal veterinary drugs. How to ensure the quality and traceability of Veterinary Medicinal Products
Illegal veterinary drugs How to ensure the quality and traceability of Veterinary Medicinal Products Catherine LAMBERT Anses/ANMV OIE Collaborating Centre on Veterinary medicinal products catherine.lambert@anses.fr
Combating Antimicrobial Resistance: A Manufacturing Perspective
Combating Antimicrobial Resistance: A Manufacturing Perspective Steve Brooks VP, EHS Pfizer Inc & Chair, Environmental Work Group of the AMR Industry Alliance June 20 th 2017 AMR - Environmental Matters
World Organisation for Animal Health
World Organisation for Animal Health 2017 Progressive Actions for Achievement of global health security Dr Susan Corning BA MSc BVSc MRCVS FRSPH Global Health Security Agenda Steering Group Meeting Geneva,
Part 2 Introduction to the OIE. Training Seminar on the OIE PVS Tool for East Asia Seoul, Republic of Korea, April 2016
Part 2 Introduction to the OIE Training Seminar on the OIE PVS Tool for East Asia Seoul, Republic of Korea, 26 28 April 2016 OIE at a glance History A scientific and technical intergovernmental organisation
YOUR COMPLETE SOURCE FOR MEDICAL MISSIONS SUPPLIES.
YOUR COMPLETE SOURCE FOR MEDICAL MISSIONS SUPPLIES. When disasters strike, Blessings International provides pharmaceuticals and medical supplies quickly, so you can bring healing to the hurting. Where
Antimicrobial susceptibility of Salmonella, 2016
susceptibility of Salmonella, 06 Hospital and community laboratories are requested to refer all Salmonella isolated from human salmonellosis cases to ESR for serotyping and the laboratory-based surveillance
GARP ACTIVITIES IN KENYA. Sam Kariuki and Cara Winters
GARP ACTIVITIES IN KENYA Sam Kariuki and Cara Winters GARP-Kenya Situation Analysis Status of Conditions Related to Antibiotic Resistance 2010 Report Organization I. Health System Overview and Disease
January 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimal Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) roth dilution: cation-adjusted Mueller-Hinton
Workplan on Antibiotic Usage Management
IMPACT Forum: Antibiotic Guideline in Perspective Workplan on Antibiotic Usage Management Dr. Raymond Yung Consultant Microbiologist PYNEH 20 April 2002 May 2002 Dr. Raymond Yung 1 Objective 1. Heighten
Pharmaceutical issues relating to STI s. June Minton Lead HIV/GUM & Infectious Diseases Pharmacist University College London Hospitals NHS Trust
Pharmaceutical issues relating to STI s June Minton Lead HIV/GUM & Infectious Diseases Pharmacist University College London Hospitals NHS Trust Objectives Treatment options for syphilis, LGV, TV, gonorrhoea
Canadian Nosocomial Infection Surveillance Program 2018 SURVEILLANCE FOR HEALTHCARE ACQUIRED CEREBROSPINAL FLUID SHUNT ASSOCIATED INFECTIONS
Canadian Nosocomial Infection Surveillance Program 2018 SURVEILLANCE FOR HEALTHCARE ACQUIRED CEREBROSPINAL FLUID SHUNT ASSOCIATED INFECTIONS FINAL November 29, 2017 Working Group: Joanne Langley (Chair),
COUNTRY PRESENTATION ON RECENT ACTIVITIES CARRIED OUT BY FOCAL POINT BHUTAN
COUNTRY PRESENTATION ON RECENT ACTIVITIES CARRIED OUT BY FOCAL POINT BHUTAN Regional Seminar for OIE National Focal Points for Veterinary Products (4th Cycle) Tokyo, Japan, 2-4 March 2016 1 Background/General
The College of Veterinarians of Ontario. Guidelines. for the Compounding of Veterinary Drugs
The College of Veterinarians of Ontario Guidelines for the Compounding of Veterinary Drugs GUIDELINES Compounding of Veterinary Drugs Approved by Council: September 26, 2007 Publication Date: Website September
Cost high. acceptable. worst. best. acceptable. Cost low
Key words I Effect low worst acceptable Cost high Cost low acceptable best Effect high Fig. 1. Cost-Effectiveness. The best case is low cost and high efficacy. The acceptable cases are low cost and efficacy
Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance
Streptococcus pneumoniae Oxacillin µg as screen for beta-lactam resistance Version 6. June Streptococcus pneumoniae and zone diameter correlates The following histograms present inhibition zone diameter
Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection Quenzer R W, Pettit K G, Arnold R J, Kaniecki D J
Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection Quenzer R W, Pettit K G, Arnold R J, Kaniecki D J Record Status This is a critical abstract of an economic evaluation
Review of requirements and processes for registration of veterinary products in selected African and Asian countries
Photo: GALVmed/Karel Prinsloo Review of requirements and processes for registration of veterinary products in selected African and Asian countries Prepared for GALVmed by Dr. Frans van Gool DVM RSBHHM